NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025
NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 Offer reference number: CM/PHR/24/5680 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 Septembe...
Buyer
NHS England
Value
£2,028,332,000
Published
17 Feb 2025
Closes
7 Apr 2025
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025
£2,028,332,000
NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 Offer reference number: CM/PHR/24/5680 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2...
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, London · United Kingdom, North East · United Kingdom, North West · United Kingdom, South East · United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
17 Feb 2025
Opportunity notice on Contracts Finder
Tender notice · Web page
Document No. 05c - Volume Discounts or Additional Products Offer Schedule - CM-PHR-24-5680
Not provided
Document No. 05c - Volume Discounts or Additional Products Offer Schedule - CM-PHR-24-5680
Excel spreadsheet
Document No. 09 - Tender Design and Instructions on Completing the Offer Schedule
Not provided
Document No. 09 - Tender Design and Instructions on Completing the Offer Schedule
Word document
Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements
Not provided
Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements
Word document
Document No. 07a - Quality Control Technical Sheet
Not provided
Document No. 07a - Quality Control Technical Sheet
Word document
Document No. 07b - Quality Assurance Policy to Support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023)
Not provided
Document No. 07b - Quality Assurance Policy to Support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023)
Word document
Document No. 08 - Confidential Information Schedule - CM_PHR_24_5680
Not provided
Document No. 08 - Confidential Information Schedule - CM_PHR_24_5680
Excel spreadsheet
Document No. 05 - Selectt Offer Schedule Instructions - CM-PHR-24-5680
Not provided
Document No. 05 - Selectt Offer Schedule Instructions - CM-PHR-24-5680
Word document
Document No. 06 - Form of Offer - CM_PHR_24_5680
Not provided
Document No. 06 - Form of Offer - CM_PHR_24_5680
Word document
Document No. 05a(ii) - Selectt Offer Schedule - CM_PHR_24_5680_02
Not provided
Document No. 05a(ii) - Selectt Offer Schedule - CM_PHR_24_5680_02
XML
Document No. 10 - Participating Authorities - CM_PHR_24_5680
Not provided
Document No. 10 - Participating Authorities - CM_PHR_24_5680
Excel spreadsheet
Document No. 02 - Terms of offer
Not provided
Document No. 02 - Terms of offer
Word document
Contains public sector information licensed under the Open Government Licence v3.0.